Whole body leucine flux in HIV-infected patients treated with or without protease inhibitors

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 4, 2006, Pages

  Prod'homme, Magali ^a,b   Rochon, Cécile ^a,b   Balage, Michèle ^a,b   Laurichesse, Henri ^c   Tauveron, Igor ^c   Champredon, Claude ^a,b   Thieblot, Philippe ^c   Beytout, Jean ^c   Grizard, Jean ^a,b  

^a CEMAGREF   (France)

^b CRNH AUVERGNE   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Amino acid requirements; Human immunodeficiency virus infection; Leucine kinetics; Protease inhibitor therapy

Indexed keywords

DIDANOSINE; IDV; INDINAVIR; LAMIVUDINE; LEUCINE; NEVIRAPINE; NVP; PROTEINASE INHIBITOR; RITONAVIR; RTV; STAVUDINE; ZALCITABINE; ZIDOVUDINE; CARBON DIOXIDE; GLUCOSE;

ADULT; ARTICLE; BODY FAT; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; GLUCOSE INFUSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS; ADIPOSE TISSUE; BLOOD; BODY COMPOSITION; HUMAN IMMUNODEFICIENCY VIRUS; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RADIODENSITOMETRY;

ADIPOSE TISSUE; ADULT; BODY COMPOSITION; CARBON DIOXIDE; DENSITOMETRY, X-RAY; GLUCOSE; HIV; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; LEUCINE; MALE; MIDDLE AGED;

EID: 33646078358     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00067.2005     Document Type: Article

References (48)

1. Allsop JR, Wolfe RR, and Burke JF. Tracer priming the bicarbonate pool. J Appl Physiol 45: 137-139, 1978.
2. Ballmer PE and Imoberdorf R. Influence of acidosis on protein metabolism. Nutrition 11: 462-468, 1995.
3. Beatty G, Khalili M, Abbasi T, Chu J, Reaven GM, Rosen A, Schmidt JM, Stansell J, and Koch J. Quantification of insulin-mediated glucose disposal in HIV-infected individuals: Comparison of patients treated and untreated with protease inhibitors. J Acquir Immune Defic Syndr 33: 34-40, 2003.
4. Berneis K, Battegay M, Bassetti S, Nuesch R, Leisibach A, Bilz S, and Keller U. Nutritional supplements combined with dietary counselling diminish whole body protein catabolism in HIV-infected patients. Eur J Clin Invest 30: 87-94, 2000.
5. Bloxam DL and Warren WH. Error in the determination of tryptophan by the method of Denkla and Dewey. A revised procedure. Anal Biochem 60: 621-625, 1974.
6. Boden G and Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest 32: 14-23, 2002.
7. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, and Cooper DA. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12: F51-F58, 1998.
8. Caron M, Auclair M, Vigouroux C, Glorian M, Forest C, and Capeau J. The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance. Diabetes 50: 1378-1388, 2001.
9. Caso G, Garlick BA, Casella GA, Sasvary D, and Garlick PJ. Acute metabolic acidosis inhibits muscle protein synthesis in rats. Am J Physiol Endocrinol Metab 287: E90-E96, 2004.
10. Collin-Vidal C, Cayol M, Obled C, Ziegler F, Bommelaer G, and Beaufrère B. Leucine kinetics are different during feeding with whole protein or oligopeptides. Am J Physiol Endocrinol Metab 267: E907-E914, 1994.
11. Creen P, Rakotoanbinina B, Raynaud JJ, Thuillier F, Messing B, and Melchior JC. Hyperphagia contributes to the normal body composition and protein-energy balance in HIV-infected asymptomatic men. J Nutr 134: 2301-2306, 2004.
12. Fedele MJ, Hernandez JM, Lang CH, Vary TC, Kimball SR, Jefferson LS, and Farrell PA. Sever diabetes prohibits elevations in skeletal muscle protein synthesis following acute resistance exercise in rats. J Appl Physiol 88: 102-108, 2000.
13. Garlick PJ. The role of leucine in the regulation of protein metabolism. J Nutr 132: 1553S-1556S, 2005.
14. Giordano M, Castellino P, and DeFronzo RA. Differential responsiveness of protein synthesis and degradation to amino acid availability in humans. Diabetes 45: 393-399, 1996.
15. Grinspoon S and Mulligan K. Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis 36: S69-S78, 2003.
16. Hardin DS, Ellis KJ, Rice J, and Doyle ME. Protease inhibitor therapy improves protein catabolism in prepubertal children with HIV infection. J Pediatr Endocrinol Metab 17: 321-325, 2004.
17. Hardin DS, LeBlanc A, Young D, and Johnson P. Increased leucine turnover and insulin resistance in men with advanced HIV infection. J Investig Med 47: 405-413, 1999.
18. 12 myocytes. Am J Physiol Cell Physiol 287: C1482-C1492, 2004.
19. Hruz PW, Murata H, and Mueckler M. Adverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanism. Am J Physiol Endocrinol Metab 280: E549-E553, 2001.
20. Jahoor F, Abramson S, and Heird WC. The protein metabolic response to HIV infection in young children. Am J Clin Nutr 78: 182-189, 2003.
21. Kotler DP, Tierney AR, Wang J, and Pierson RN. Magnitude of body cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 50: 444-447, 1989.
22. Kotler DP, Wang J, and Pierson RN. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 42: 1255-1265, 1985.
23. Laurichesse H, Tauveron I, Gourdon F, Cormerais L, Champredon C, Charrier S, Rochon C, Lamain S, Bayle G, Laveran H, Thieblot P, Beytout J, and Grizard J. Threonine and methionine are limiting amino acids for protein synthesis in patients with AIDS. J Nutr 128: 1342-1348, 1998.
24. Lee H, Hanes J, and Johson KA. Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. Biochemistry 42: 14711-14719, 2003.
25. Lewis W, Copeland WC, and Day BJ. Mitochondrial DNA depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors. Lab Invest 81: 777-790, 2001.
26. Macallan DC, McNurlan MA, Milne E, Calder AG, Garlick PJ, and Griffin GE. Whole-body protein turnover from leucine kinetics and the response to nutrition in human immunodeficiency virus infection. Am J Clin Nutr 61: 818-826, 1995.
27. Marceau G, Sapin V, Jacomet C, Ughetto S, Cormerais L, Regagnon C, Dastugue B, Peigue-Lafeuille H, Beytout J, and Laurichesse H. Frequency, risk factors, and outcome of hyperlactatemia in HIV-positive persons: implications for the management of treated patients. Clin Chem 49: 1154-1162, 2003.
28. 13C]leucine. Am J Physiol Endocrinol Metab 238: E473-E479, 1980.
29. Nair SK and Short KR. Hormonal and signaling role of branched-chain amino acids. J Nutr 135: 1547S-1552S, 2005.
30. Nygren J and Nair KS. Differetial regulation of protein dynamics in splanchnic and skeletal muscle beds by insulin and amino acids in healthy human subjects. Diabetes 52: 1377-1385, 2003.
31. Paton NI, Ng YM, Chee CB, Persaud C, and Jackson AA. Effects of tuberculosis and HIV infection on whole-body protein metabolism during feeding, measured by the [15N]glycine method. Am J Clin Nutr 78: 319-325, 2003.
32. Penzak SR and Chuck SK. Hyperlipidemia associated with HIV protease inhibitor use: pathophysiology, prevalence, risk factors and treatment. Scand J Infect Dis 32: 111-123, 2000.
33. Pernerstorfer-Schoen H, Schindler K, Parschalk B, Schindl A, Thoeny-Lampert S, Wunderer K, Elmadfa I, Tschachler E, and Jilma B. Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients. AIDS 13: 2389-2396, 1999.
34. Prod'homme M, Rieu I, Balage M, Dardevet D, and Grizard J. Insulin and amino acids both strongly participate to the regulation of protein metabolism. Curr Opin Clin Nutr Metab Care 7: 71-77, 2004.
35. Reeds PJ. Isotopic estimation of protein synthesis and proteolysis in vivo. In: Modern Methods in Protein Nutrition and Metabolism, edited by Nissen S. San Diego, CA: Academic, 1992, p. 249-273.
36. Rennie MJ, Bohé J, and Wolfe RR. Latency, duration and dose response relationships of amino acid effects on human muscle protein synthesis. J Nutr 132: 3225S-3227S, 2002.
37. Safrin S and Grunfeld C. Fat distribution and metabolic changes in patients with HIV infection. AIDS 13: 2493-2505, 1999.
38. Salomon J, DeTruchis P, and Melchior JC. Nutrition and HIV infection. Br J Nutr 87: S111-S119, 2002.
39. Selberg O, Süttmann U, Melzer A, Deicher H, Müller MJ, Henkel E, and McMillan DC. Effect of increased protein intake and nutritional status on whole-body protein metabolism of AIDS patients with weight loss. Metabolism 44: 1159-1165, 1995.
40. Stein TP, Nutinsky C, Condoluci D, Schluter MD, and Leskiw MJ. Protein and energy substrate metabolism in AIDS patients. Metabolism 39: 876-881, 1990.
41. Tauveron I, Charrier S, Champredon C, Bonnet Y, Berry C, Bayle G, Prugnaud J, Obled C, Grizard J, and Thiéblot P. Response of leucine metabolism to hyperinsulinemia under amino acid replacement in experimental hyperthyroidism. Am J Physiol Endocrinol Metab 269: E499-E507, 1995.
42. Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, and Yarasheski KE. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14: F63-F67, 2000.
43. Tesseraud S, Grizard J, Debras E, Papet I, Bonnet Y, Bayle G, and Champredon C. Leucine metabolism in lactating and dry goats: effect of insulin and substrate availability. Am J Physiol Endocrinol Metab 265: E402-E413, 1993.
44. Watt PW, Lindsay Y, Scrimgeour CM, Chien PA, Gibson JNA, Taylor DJ, and Rennie MJ. Isolation of aminoacyl-tRNA and its labeling with stable-isotope tracers: use in studies of human tissue protein synthesis. Proc Natl Acad Sci USA 88: 5892-5896, 1991.
45. Woerle HJ, Mariuz PR, Meter C, Reichman RC, Popa EM, Dostou JM, Welle SL, and Gerich JE. Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens. Diabetes 52: 918-925, 2003.
46. Yanovski JA, Miller KD, Kino T, Friedman TC, Chrousos GP, Tsigos C, and Falloon J. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy. J Clin Endocrinol Metab 84: 1925-1931, 1999.
47. Yarasheski KE, Smith SR, and Powderly WG. Reducing plasma HIV RNA improves muscle amino acid metabolism. Am J Physiol Endocrinol Metab 288: E278-E284, 2005.
48. a and inappropriately low muscle protein synthesis rate in AIDS wasting. Am J Physiol Endocrinol Metab 275: E577-E583, 1998.